China · Delayed Price · Currency is CNY Hybio Pharmaceutical Statistics
Total Valuation
SHE:300199 has a market cap or net worth of CNY 20.02 billion. The enterprise value is 21.80 billion.
| Market Cap | 20.02B |
| Enterprise Value | 21.80B |
Important Dates
The last earnings date was Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300199 has 883.24 million shares outstanding. The number of shares has increased by 11.56% in one year.
| Current Share Class | 883.24M |
| Shares Outstanding | 883.24M |
| Shares Change (YoY) | +11.56% |
| Shares Change (QoQ) | -7.95% |
| Owned by Insiders (%) | 24.83% |
| Owned by Institutions (%) | 5.43% |
| Float | 643.98M |
Valuation Ratios
The trailing PE ratio is 159.29.
| PE Ratio | 159.29 |
| Forward PE | n/a |
| PS Ratio | 18.12 |
| PB Ratio | 23.14 |
| P/TBV Ratio | 38.43 |
| P/FCF Ratio | 913.66 |
| P/OCF Ratio | 52.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 59.61, with an EV/FCF ratio of 994.79.
| EV / Earnings | 170.58 |
| EV / Sales | 19.73 |
| EV / EBITDA | 59.61 |
| EV / EBIT | 99.09 |
| EV / FCF | 994.79 |
Financial Position
The company has a current ratio of 0.46, with a Debt / Equity ratio of 2.21.
| Current Ratio | 0.46 |
| Quick Ratio | 0.19 |
| Debt / Equity | 2.21 |
| Debt / EBITDA | 5.24 |
| Debt / FCF | 87.32 |
| Interest Coverage | 4.62 |
Financial Efficiency
Return on equity (ROE) is 15.58% and return on invested capital (ROIC) is 6.64%.
| Return on Equity (ROE) | 15.58% |
| Return on Assets (ROA) | 3.96% |
| Return on Invested Capital (ROIC) | 6.64% |
| Return on Capital Employed (ROCE) | 11.26% |
| Weighted Average Cost of Capital (WACC) | 7.64% |
| Revenue Per Employee | 901,465 |
| Profits Per Employee | 104,243 |
| Employee Count | 1,226 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.44 |
Taxes
In the past 12 months, SHE:300199 has paid 32.88 million in taxes.
| Income Tax | 32.88M |
| Effective Tax Rate | 20.81% |
Stock Price Statistics
The stock price has decreased by -17.09% in the last 52 weeks. The beta is 0.71, so SHE:300199's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -17.09% |
| 50-Day Moving Average | 23.12 |
| 200-Day Moving Average | 20.71 |
| Relative Strength Index (RSI) | 49.56 |
| Average Volume (20 Days) | 54,650,459 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300199 had revenue of CNY 1.11 billion and earned 127.80 million in profits. Earnings per share was 0.14.
| Revenue | 1.11B |
| Gross Profit | 632.36M |
| Operating Income | 219.60M |
| Pretax Income | 158.02M |
| Net Income | 127.80M |
| EBITDA | 364.50M |
| EBIT | 219.60M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 150.79 million in cash and 1.91 billion in debt, with a net cash position of -1.76 billion or -2.00 per share.
| Cash & Cash Equivalents | 150.79M |
| Total Debt | 1.91B |
| Net Cash | -1.76B |
| Net Cash Per Share | -2.00 |
| Equity (Book Value) | 865.16M |
| Book Value Per Share | 1.01 |
| Working Capital | -864.52M |
Cash Flow
In the last 12 months, operating cash flow was 382.22 million and capital expenditures -360.30 million, giving a free cash flow of 21.92 million.
| Operating Cash Flow | 382.22M |
| Capital Expenditures | -360.30M |
| Depreciation & Amortization | 144.89M |
| Net Borrowing | -388.97M |
| Free Cash Flow | 21.92M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 57.22%, with operating and profit margins of 19.87% and 11.56%.
| Gross Margin | 57.22% |
| Operating Margin | 19.87% |
| Pretax Margin | 14.30% |
| Profit Margin | 11.56% |
| EBITDA Margin | 32.98% |
| EBIT Margin | 19.87% |
| FCF Margin | 1.98% |
Dividends & Yields
SHE:300199 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 75.36% |
| Buyback Yield | -11.56% |
| Shareholder Yield | -11.56% |
| Earnings Yield | 0.64% |
| FCF Yield | 0.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 14, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Apr 14, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |